Style | Citing Format |
---|---|
MLA | Jafariaghdam N, et al.. "Methylprednisolone Acetate-Eudragit® Rs100 Electrospuns: Preparation and Physicochemical Characterization." Artificial Cells# Nanomedicine and Biotechnology, vol. 44, no. 2, 2016, pp. 497-503. |
APA | Jafariaghdam N, Adibkia K, Payab S, Barzegarjalali M, Parvizpur A, Mohammadi G, Sabzevari A (2016). Methylprednisolone Acetate-Eudragit® Rs100 Electrospuns: Preparation and Physicochemical Characterization. Artificial Cells# Nanomedicine and Biotechnology, 44(2), 497-503. |
Chicago | Jafariaghdam N, Adibkia K, Payab S, Barzegarjalali M, Parvizpur A, Mohammadi G, Sabzevari A. "Methylprednisolone Acetate-Eudragit® Rs100 Electrospuns: Preparation and Physicochemical Characterization." Artificial Cells# Nanomedicine and Biotechnology 44, no. 2 (2016): 497-503. |
Harvard | Jafariaghdam N et al. (2016) 'Methylprednisolone Acetate-Eudragit® Rs100 Electrospuns: Preparation and Physicochemical Characterization', Artificial Cells# Nanomedicine and Biotechnology, 44(2), pp. 497-503. |
Vancouver | Jafariaghdam N, Adibkia K, Payab S, Barzegarjalali M, Parvizpur A, Mohammadi G, et al.. Methylprednisolone Acetate-Eudragit® Rs100 Electrospuns: Preparation and Physicochemical Characterization. Artificial Cells# Nanomedicine and Biotechnology. 2016;44(2):497-503. |
BibTex | @article{ author = {Jafariaghdam N and Adibkia K and Payab S and Barzegarjalali M and Parvizpur A and Mohammadi G and Sabzevari A}, title = {Methylprednisolone Acetate-Eudragit® Rs100 Electrospuns: Preparation and Physicochemical Characterization}, journal = {Artificial Cells# Nanomedicine and Biotechnology}, volume = {44}, number = {2}, pages = {497-503}, year = {2016} } |
RIS | TY - JOUR AU - Jafariaghdam N AU - Adibkia K AU - Payab S AU - Barzegarjalali M AU - Parvizpur A AU - Mohammadi G AU - Sabzevari A TI - Methylprednisolone Acetate-Eudragit® Rs100 Electrospuns: Preparation and Physicochemical Characterization JO - Artificial Cells# Nanomedicine and Biotechnology VL - 44 IS - 2 SP - 497 EP - 503 PY - 2016 ER - |